Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients

Transplant Immunology

Volumn 30, Issue 1, 2014, Pages 18-23

  Wang, Xu Zhen ^a   Jin, Zhan Kui ^b   Tian, Xiao Hui ^a,b   Xue, Wu Jun ^a,b   Tian, Pu Xun ^a,b   Ding, Xiao Ming ^a,b   Zheng, Jin ^a,b   Li, Yang ^a   Jing, Xin ^a   Luo, Zi Zhen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acute rejection; Adenosine triphosphate (ATP); Kidney transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC KIT; DISEASE COURSE; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PATIENT CODING; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ACUTE DISEASE; CELL COUNT; CONTROLLED CLINICAL TRIAL; GRAFT REJECTION; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; MIDDLE AGED; PROGNOSIS; TRANSPLANTATION;

ACUTE DISEASE; ADENOSINE TRIPHOSPHATE; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CYCLOSPORINE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SPACE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; TACROLIMUS; TRANSPLANTATION;

EID: 84891833614     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.10.008     Document Type: Article

References (26)

1. Nashan B., Moore R., Amlot P., Schmidt A.G., Abeywickrama K., Soulillou J.P. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997, 350(9086):1193-1198.
2. Choi B.S., Shin M.J., Shin S.J., Kim Y.S., Choi Y.J., Kim Y.S., et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant 2005, 5(6):1354-1360.
3. Kowalski R.J., Post D.R., Mannon R.B., Sebastian A., Wright H.I., Sigle G., et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006, 82(5):663-668.
4. Kowalski R., Post D., Schneider M.C., Britz J., Thomas J., Deierhoi M., et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003, 17(2):77-88.
5. Cadillo-Chávez R., de Echegaray S., Santiago-Delpín E.A., Rodríguez-Trinidad A.T., Camacho-Carrazo B., Alfaro T., et al. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Transplant Proc 2006, 38(3):918-920.
6. Cabrera R., Ararat M., Soldevila-Pico C., Dixon L., Pan J.J., Firpi R., et al. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patient. Liver Transpl 2009, 15(2):216-222.
7. Dong J.Y., Yin H., Li R.D., Ding G.S., Fu Z.R., Wu Y.M., et al. The relationship between adenosine triphosphate within CD4(+) T lymphocytes and acute rejection after liver transplantation. Clin Transplant 2011, 25(3):E292-E296.
8. Ling X.T., Xiong J., Liang W.H., Paul M.S., Wu L.W., Ju W.Q., et al. Can immune cell function assay identify patients at risk of infection or rejection? a meta-analysis. Transplantation 2012, 93(7):737-743.
9. Betjes M.G. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol 2013, 9(5):255-265.
10. De Paolis P., Favaro A., Piola A., Martini F., Cristiana G., Agrati C., et al. "ImmuKnow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation. Transplant Proc 2011, 43(4):1013-1016.
11. Torio A., Fernandez E.J., Montes-Ares O., Guerra R.M., Perez M.A., Checa M.D. Lack of association of immune cell function test with rejection in kidney transplantation. Transplant Proc 2011, 43(6):2168-2170.
12. Serban G., Whittaker V., Fan J., Liu Z., Manga K., Khan M., et al. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy. Hum Immunol 2009, 70(11):882-890.
13. Huskey J., Gralla J., Wiseman A.C. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection. Clin J Am Soc Nephrol 2011, 6(2):423-429.
14. Israeli M., Yussim A., Mor E., Sredni B., Klein T. Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform. Transpl Immunol 2007, 18(1):7-12.
15. Israeli M., Ben-Gal T., Yaari V., Valdman A., Matz I., Medalion B., et al. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests. Transplantation 2010, 89(8):968-976.
16. Hwang S., Kim K.H., Song G.W., Yu Y.D., Park G.C., Kim K.W., et al. Peritransplant monitoring of immune cell function in adult living donor liver transplantation. Transplant Proc 2010, 42(7):2567-2571.
17. Israeli M., Klein T., Sredni B., Avitzur Y., Mor E., Bar-Nathen N., et al. ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl 2008, 14(6):893-898.
18. Mizuno S., Hamada T., Nakatani K., Kishiwada M., Usui M., Sakurai H., et al. Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype. J Hepatobiliary Pancreat Sci 2011, 18(2):226-232. [discussion 32-4].
19. Sampson V.B., Dunn S.P., Rymeski B., Malatack J., Rong N.H., Flynn L., et al. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. J Pediatr Surg 2008, 43(6):1134-1141.
20. Schulick R.D., Weir M.B., Miller M.W., Cohen D.J., Bermas B.L., Shearer G.M. Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. Transplantation 1993, 56(3):590-596.
21. Ahmed M., Venkataraman R., Logar A.J., Rao A.S., Bartley G.P., Robert K., et al. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells. Ther Drug Monit 2001, 23(4):354-362.
22. Ravaioli M., Morelli C., Del Gaudio M., Zanello M., Berardi S., Ercolani G., et al. Immunosuppression monitoring by Cylex ImmuKnow test after liver transplantation: preliminary results of randomized prospective trial [abstract]. Transpl Int 2011, 24(Suppl. 2):227.
23. Xue F., Zhang J., Han L., Li Q., Xu N., Zhou T., et al. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. Transplantation 2010, 89(5):620-626.
24. Husain S., Raza K., Pilewski J.M., Zaldonis D., Crespo M., Toyoda Y., et al. Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection. Transplantation 2009, 87(12):1852-1857.
25. Sanchez-Velasco P., Rodrigo E., Valero R., Ruiz J.C., Fernandez-Fresnedo G., Lopez-Hoyos M., et al. Intracellular ATP concentrations of CD4 cells in kidney transplant patients with and without infection. Clin Transplant 2008, 22(1):55-60.
26. Zhou T., Xue F., Han L.Z., Xi Z.F., Li Q.G., Xu N., et al. Invasive fungal infection after liver transplantation: risk factors and significance of immune cell function monitoring. J Dig Dis 2011, 12(6):467-475.